|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-11-8
|
|
pubmed:abstractText |
The prostate cancer prevention trial (PCPT) prostate cancer risk calculator was developed to aid physicians in counseling men for consideration of prostate biopsy based on prostate-specific antigen (PSA) and other clinical risk factors. This study investigated the role of body mass index (BMI) in this assessment.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Published by Elsevier Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1268.e1-6
|
|
pubmed:dateRevised |
2011-11-1
|
|
pubmed:meshHeading |
pubmed-meshheading:20739049-Adult,
pubmed-meshheading:20739049-Aged,
pubmed-meshheading:20739049-Body Mass Index,
pubmed-meshheading:20739049-Digital Rectal Examination,
pubmed-meshheading:20739049-Humans,
pubmed-meshheading:20739049-Male,
pubmed-meshheading:20739049-Middle Aged,
pubmed-meshheading:20739049-Obesity,
pubmed-meshheading:20739049-Prostate-Specific Antigen,
pubmed-meshheading:20739049-Prostatic Neoplasms,
pubmed-meshheading:20739049-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
|
|
pubmed:affiliation |
Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. liangy@uthscsa.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
